Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-017860
Filing Date
2022-11-14
Accepted
2022-11-14 17:12:34
Documents
67
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q krbp-20220930x10q.htm   iXBRL 10-Q 1856916
2 EX-31.1 krbp-20220930xex31d1.htm EX-31.1 23215
3 EX-31.2 krbp-20220930xex31d2.htm EX-31.2 19819
4 EX-32.1 krbp-20220930xex32d1.htm EX-32.1 7893
5 EX-32.2 krbp-20220930xex32d2.htm EX-32.2 8014
  Complete submission text file 0001558370-22-017860.txt   7185948

Data Files

Seq Description Document Type Size
6 EX-101.SCH krbp-20220930.xsd EX-101.SCH 42664
7 EX-101.CAL krbp-20220930_cal.xml EX-101.CAL 40635
8 EX-101.DEF krbp-20220930_def.xml EX-101.DEF 192611
9 EX-101.LAB krbp-20220930_lab.xml EX-101.LAB 418603
10 EX-101.PRE krbp-20220930_pre.xml EX-101.PRE 324810
61 EXTRACTED XBRL INSTANCE DOCUMENT krbp-20220930x10q_htm.xml XML 1291268
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

EIN.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39619 | Film No.: 221387567
SIC: 2836 Biological Products, (No Diagnostic Substances)